Advanced Cardiac Therapeutics, Inc., a developer of innovative
temperature-sensing cardiac ablation systems, today announced results of
several studies related to the company's TEMPASURE™ cardiac ablation
catheter. The TEMPASURE system is designed to improve clinical outcomes
with a novel microwave radiometry technology that allows the
electrophysiologist to measure the temperature of cardiac tissue during
the ablation procedure, providing real-time information that enables
proper energy delivery and lesion control. Presentations took place at
the Heart Rhythm Society's 33rd Annual Scientific Sessions in Boston,
Mass.
Jacob Koruth, M.D., of Mt. Sinai School of Medicine in New York
presented results of a preclinical study confirming the ability of the
TEMPASURE system to predict 'steam pops,' a risk of irrigated
radiofrequency (RF) catheter ablation that can cause cardiac
perforation, which can have severe clinical consequences.
"This pre-clinical study demonstrates that the TEMPASURE's ability to
measure tissue temperature during irrigated RF ablation allows for
accurate prediction of steam pops," said Vivek Reddy, M.D., F.A.C.C.,
director of Electrophysiology Laboratories at Mt. Sinai Medical Center,
who serves on the company's medical advisory board. "This represents a
major step forward in catheter ablation because, with the precise
temperature measurements possible with TEMPASURE during the ablation
procedure, we can now eradicate this major safety concern for the
electrophysiologist. I anticipate that TEMPASURE will also give the
physician more confidence in the quality of each RF application."